The treatment for thalassemia can vary greatly according to the individual circumstances and the presenting symptoms. Some patients may carry a gene mutation but not experience any symptoms, also ...

Beta-thalassemia, also called Cooley’s Anemia, is a blood disease that effects thousands of Americans. In a major step toward a curative therapy, rare disease drug development firm Errant Gene ...

Orphan drug designation incentives have helped boost enthusiasm for researching and developing drugs for beta thalassemia, a new review concludes. The review encompassed all beta-thalassemia drugs ...

In 1976, my final year of medical school, I travelled abroad and spent several months working in the hematology clinic at Hadassah Hospital, in Jerusalem. Every day, I attended to children and ...

REBLOZYL is the first and only FDA-approved erythroid maturation agent, representing a new class of therapy for these patients Approval of REBLOZYL marks the first FDA-approved treatment for anemia in ...

FRANKFURT, Germany — Updated results released Friday highlighted the lasting benefits of a CRISPR-based medicine for blood disorders developed by Vertex Pharmaceuticals and CRISPR Therapeutics, as the ...

Doctors who treated patients with sickle cell disease who received an infusion of gene-edited treatment have called it "transformative" for those who live with a chronic condition. The technique calls ...

Italian scientists pioneering a new gene transfer treatment for the blood disorder beta-thalassemia have successfully completed preclinical trials, claiming they can correct the lack of beta-globin in ...

Go to source). The 2026 campaign focuses on strengthening global action and improving patient care across countries. Health organizations are emphasizing early diagnosis, better treatment access, and ...

KUALA LUMPUR: It costs around RM3mil to treat a thalassemia patient from infancy up to the age of 40, says Datuk Seri Dr Dzulkefly Ahmad. The Health Minister revealed that 9,554 patients are currently ...